Trade-Ideas: Thursday, Monday, August 12th, 2019Trade ideas for next week:1) BDSI $4.36* Continuation swing opportunity.* Gained 16% last week.* Released strong earnings last week with strong revenue … [Read more...] about Trade-Ideas for Monday, August 12th, 2019
stocks
Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
Foamix Pharmaceuticals (NASDAQ: FOMX) shares have been on a free fall for the past six months, declining by more than 30 percent to $2.3. The clinical-stage company which develops and commercializes … [Read more...] about Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
Immunomedics’ Risk vs. Reward
Press play on chart to watch IMMU trade in real-time. #IMMU look at Risk vs. Reward #Volatilitywatch by follow_the_money on TradingView.com Immunomedics Inc. (Nasdaq: IMMU) brings … [Read more...] about Immunomedics’ Risk vs. Reward
Biopharma Stock Watch July 8th-12
Source: MS Money Moves Overall it was a red week for biotech whereas the greater market (S&P, NASDAQ, and DOW) gained a little under +1% each. In the past 30-days the healthcare sector … [Read more...] about Biopharma Stock Watch July 8th-12
Krystal Biotech (NASDAQ: KRYS) is On Track to Bring the First “Off the Shelf” Gene Therapy to Market
While writing my weekly Biopharma Stock Watch article for our members, I stumbled across an exciting clinical-stage gene therapy company Krystal Biotech (Nasdaq: KRYS). Since we started following KRYS … [Read more...] about Krystal Biotech (NASDAQ: KRYS) is On Track to Bring the First “Off the Shelf” Gene Therapy to Market
Evolus: A Performance Beauty Company “Built to Grow Overnight”: Part 2
To recap, in part 1 we talked about Evolus (Nasdaq: EOLS), a relatively young company (no pun intended) entering the medical aesthetics market. Their first product Jeuveau was approved by FDA in … [Read more...] about Evolus: A Performance Beauty Company “Built to Grow Overnight”: Part 2
Oncology Lesson 2
In this video; Chris Stang MS CPO provides education on the different kinds of Oncology present in todays market. Be sure to Subscribe for the next lesson! … [Read more...] about Oncology Lesson 2
Global ESG Portfolios: Part 1
This summer I'm living in Japan, uniquely positioning me to observe some of the key metrics for ESGs through a global lens. This article will be part one of a multi part series covering ESG funds … [Read more...] about Global ESG Portfolios: Part 1
DVAX Restructuring Surprise; Was A Sell-Off The Right Reaction?
Sometimes during the lifetime of a company significant shifts in priorities and resource allocation are made. I believe the ability to recognize the need for such changes and the wherewithal to carry … [Read more...] about DVAX Restructuring Surprise; Was A Sell-Off The Right Reaction?
Investor Alert: Endra Life Scienes (NDRA)
Background Endra Life Sciences (NDRA) is a clinical stage medical device company we started following in April, 2019. The share price galloped up to a high near $3.30 in March in anticipation of … [Read more...] about Investor Alert: Endra Life Scienes (NDRA)